International Biotechnology Trust’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $758K | Hold |
24,000
| – | – | 0.26% | 55 |
|
|
2023
Q2 | $978K | Hold |
24,000
| – | – | 0.3% | 46 |
|
|
2023
Q1 | $894K | Hold |
24,000
| – | – | 0.25% | 52 |
|
|
2022
Q4 | $837K | Hold |
24,000
| – | – | 0.26% | 53 |
|
|
2022
Q3 | $1.34M | Buy |
24,000
+22,758
| +1,832% | +$1.27M | 0.43% | 48 |
|
|
2022
Q2 | $24K | Sell |
1,242
-22,758
| -95% | -$440K | 0.25% | 60 |
|
|
2022
Q1 | $511K | Hold |
24,000
| – | – | 0.12% | 64 |
|
|
2021
Q4 | $2.84M | Buy |
+24,000
| New | +$2.84M | 0.63% | 37 |
|